Impact of Door-to-Needle Time on Stroke Outcomes at Gonesse Hospital

This study looks at how quickly stroke patients receive treatment after arriving at Gonesse Hospital and whether this affects their recovery. Researchers will measure the time between a patient's arrival and the start of clot-busting treatment (called Door-to-Needle Time), as well as the time from symptom onset to hospital arrival (Home-Time). The goal is to see if treatment delays impact recovery, and to find ways to improve stroke care in the hospital.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Stroke Brain Diseases Brain Infarction Brain Ischemia Cardiovascular Diseases Central Nervous System Diseases Cerebral Infarction Cerebrovascular Disorders Infarction Ischemia Ischemic Attack, Transient Necrosis Nervous System Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Thrombolytic Therapy Treatment Outcome Vascular Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

France

Gonesse, France

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients aged 18 years or older
Confirmed diagnosis of acute ischemic stroke on imaging
Initial acute stroke care provided at Gonesse Hospital during the study period (3 months)
Intravenous thrombolysis (r-tPA) initiated at the hospital
Availability of clinical and timing data to calculate Door-to-Needle Time (DNT)

Exclusion criteria

Patients with hemorrhagic stroke or subarachnoid hemorrhage (SAH)
Thrombolysis initiated before hospital arrival
Missing, incomplete, or unusable timing data for DNT calculation

Treatment and study plan

Primary outcomes

Time (in minutes) from hospital arrival to thrombolysis (Door-to-Needle Time).

Time frame: 3 months

Sponsors and collaborators

Lead sponsor

Centre Hospitalier de Gonesse

Other

Registry information

Important dates

Study start: 2025
Primary completion: 2025
Study completion: 2025
First posted: Jun 12, 2025
Registry last updated: Jun 12, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed